Back to the main directory
Company Analysis / Equity
- Morningstar | Virtus Health Faces Domestic Challenges by Growing Offshore by Morningstar
- Morningstar | Cost Pressure Weighs on Asaleo's Earnings, While Balance Sheet Pressure See Dividends Suspended by Morningstar
- Basilea Pharmaceutica - Cresemba growth, pipeline expansion by Edison Investment Research
- Morningstar | Raising EDF's FVE by 42% to EUR 15 and Lowering Uncertainty to Medium; Shares Undervalued by Morningstar
- Morningstar | Kerry's Interim Earnings Miss Due to Project Impairment, but Major Segments in Line by Morningstar
- Lakehouse - Promised disposals achieved by Edison Investment Research
- Jyske 1H 2018 Results In Line With Our Expectations; Maintaining FVE by Morningstar
- Morningstar | Jyske 1H 2018 Results In Line With Our Expectations; Maintaining FVE by Morningstar
- Morningstar | Weak Volumes Affect Narrow-Moat Amcor in Fiscal 2018; FVE Reduced to AUD 14.60 by Morningstar
- Morningstar | BBVA has a solid leadership position in Spain. by Morningstar
- Morningstar | Outlook for Coca-Cola Femsa Intact Despite Pending Exit From Philippines by Morningstar
- Lennox Discloses Financial Impact of Tornado-Damaged Manufacturing Facility; Lowers 2018 Guidance by Morningstar
- Morningstar | Competition Picks Up in Liver Cancer With Lenvima Approval; Decreasing Exelixis FVE to $28. See Updated Analyst Note from 21 Aug 2018 by Morningstar
- Morningstar | Evergrande Proposes Dividend Payment for 2016, 2017 in Lieu of Special Dividend Upon A-Share Listing by Morningstar
- Kohl’s Makes Progress on Its Greatness Agenda, but Shares Remain Overvalued by Morningstar
- Upgrading Shimao FVE on Strong Year-to-Date Contract Sales by Morningstar
- Morningstar | Premier's Full-Year Results Exceed Expectations and Reinforce Our Narrow Moat Rating; Raising FVE by Morningstar
- Morningstar | Pension Fund Purchasing a 50% Stake in BridgeTex, Generating a Windfall for Magellan and Plains by Morningstar
- Morningstar | Pension Fund Purchasing a 50% Stake in BridgeTex, Generating a Windfall for Magellan and Plains by Morningstar
- Morningstar | We expect emerging-market opportunities will help PerkinElmer, but M&A record gives us pause. by Morningstar
- Morningstar | Acquisitions should continue to help Hikma compete in the global generic drug industry. by Morningstar
- Morningstar | TJX Continues Its Strong Execution, Leveraging a Cost Advantage in Service of a Differentiated Model by Morningstar
- Smucker Posts Tepid 1Q Results With Pet Food Lagging, Outlook Intact; Shares Attractive by Morningstar
- Wipro Continues to Juggle Ups and Downs; BFSI a Bright Spot; Local Shares Modestly Undervalued by Morningstar
- Straumann's clear aligner expansion should boost performance, but margins face long-term pressure. by Morningstar